Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0030
-0.0002 (-6.25%)
Apr 24, 2026, 5:04 PM CET

STO:LPGO Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2517541663
Market Cap Growth
-89.63%-69.56%-68.58%240.70%-74.72%-
Enterprise Value
-8-11629024
Last Close Price
0.000.010.090.330.614.43
PS Ratio
--1.663.32-28.61
PB Ratio
0.230.662.211.924.132.76
P/TBV Ratio
0.230.662.211.924.132.76
EV/Sales Ratio
--0.621.78-10.68
Net Debt / Equity Ratio
-1.29-1.29-1.52-1.12-2.49-1.24
Net Debt / EBITDA Ratio
0.320.320.442.380.250.68
Net Debt / FCF Ratio
0.280.280.472.230.260.80
Asset Turnover
--0.430.74-0.10
Quick Ratio
3.033.031.966.431.534.49
Current Ratio
3.153.152.076.511.554.54
Return on Equity (ROE)
-413.94%-413.94%-139.56%-75.06%-281.03%-228.75%
Return on Assets (ROA)
-153.42%-153.42%-69.50%-37.84%-118.44%-117.98%
Return on Capital Employed (ROCE)
-408.00%-408.00%-346.90%-47.30%-985.10%-183.60%
Earnings Yield
-1784.46%-622.49%-147.59%-22.26%-235.76%-64.99%
FCF Yield
-1973.87%-688.56%-146.14%-26.28%-234.27%-55.99%
Buyback Yield / Dilution
-191.76%-191.76%-115.86%-336.30%-63.10%-104.09%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.